Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Filed by PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-04 06:26:19 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Nov 3, 2026
Income
Not reported
Expenses
$50,000.00
Filing UUID
f10cbcd2-dfad-44d8-9f12-43b9a91d3317
Termination date
Not reported

Expense method: C

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness and transparency of biopharmaceutical supply chains (incl. CLEAR LABELS Act), drug shortages, and workforce development

HCR · Health Issues

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness and transparency of biopharmaceutical supply chains (incl. CLEAR LABELS Act), drug shortages, and workforce development

MAN · Manufacturing

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness and transparency of biopharmaceutical supply chains (incl. CLEAR LABELS Act), drug shortages, and workforce development

TAR · Tariff (miscellaneous tariff bills)

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness and transparency of biopharmaceutical supply chains (incl. CLEAR LABELS Act), drug shortages, and workforce development

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.